These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15485679)

  • 1. Current status of catheter- and stent-based gene therapy.
    Sharif F; Daly K; Crowley J; O'Brien T
    Cardiovasc Res; 2004 Nov; 64(2):208-16. PubMed ID: 15485679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site specific gene delivery in the cardiovascular system.
    Fishbein I; Stachelek SJ; Connolly JM; Wilensky RL; Alferiev I; Levy RJ
    J Control Release; 2005 Dec; 109(1-3):37-48. PubMed ID: 16298010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel anti-DNA antibody modified coronary stent for site-specific plasmid DNA delivery].
    Jin X; Leng XG; Liu LX; Gu HG; Zhang C; Wang H; Song CX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):665-9. PubMed ID: 17121228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal.
    Swain JD; Katz MG; White JD; Thesier DM; Henderson A; Stedman HH; Bridges CR
    Methods Mol Biol; 2011; 709():331-54. PubMed ID: 21194039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic therapy.
    Simari RD; Nabel EG
    Semin Interv Cardiol; 1996 Mar; 1(1):77-83. PubMed ID: 9552497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factoring nonviral gene therapy into a cure for hemophilia A.
    Gabrovsky V; Calos MP
    Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation.
    Akagi D; Oba M; Koyama H; Nishiyama N; Fukushima S; Miyata T; Nagawa H; Kataoka K
    Gene Ther; 2007 Jul; 14(13):1029-38. PubMed ID: 17460721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy.
    Zhao Y; Keating K; Thorpe R
    Toxicol Appl Pharmacol; 2007 Dec; 225(2):189-97. PubMed ID: 17904176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical applications of imaging for cancer gene therapy.
    Briat A; Vassaux G
    Expert Rev Mol Med; 2006 Jul; 8(16):1-19. PubMed ID: 16842637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah M; Vandendriessche T
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
    Chen JP
    J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering chromosomes for delivery of therapeutic genes.
    Irvine DV; Shaw ML; Choo KH; Saffery R
    Trends Biotechnol; 2005 Dec; 23(12):575-83. PubMed ID: 16242803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large preclinical animal model to assess ex vivo skin gene therapy applications.
    Pfützner W; Joari MR; Foster RA; Vogel JC
    Arch Dermatol Res; 2006 Jun; 298(1):16-22. PubMed ID: 16565820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.